Pace Of Omicron Variants Hindering Work On Adapted COVID-19 Vaccines

 
• By Ian Schofield

The European Medicines Agency says regulators are currently discussing the extent to which clinical data will have to be submitted to support the approval of an adapted vaccine against Omicron variants.

Researcher with blood sample of New Variant of the Covid-19 Omicron
Vaccines are needed to tackle new SARS-CoV-2 variants • Source: Shutterstock

More from Europe

More from Geography